Form 4: Tevogen Bio Holdings Director Receives 240,000 Restricted Stock Units

A Tevogen Bio Holdings director, Jeffrey L. Feike, was granted 240,000 restricted stock units (RSUs) on December 23, 2024, which will vest over four years.

Summary

• Jeffrey L. Feike, a director at Tevogen Bio Holdings Inc., received a grant of 240,000 restricted stock units (RSUs) on December 23, 2024.
• These RSUs were granted under the company's 2024 Omnibus Incentive Plan.
• The RSUs will vest in four equal annual installments, starting on January 1, 2025.
• Vesting is contingent upon Mr. Feike's continued service with Tevogen Bio Holdings.
• Each RSU represents the right to receive one share of Tevogen Bio Holdings' common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, which is generally positive for aligning management and shareholder interests. There are no negative implications.

Positives

• The grant of RSUs aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Risks

• The vesting of the RSUs is contingent on the director's continued service, which introduces a risk of forfeiture if the director leaves the company before full vesting.

Future Outlook

The RSUs will vest over the next four years, contingent on the director's continued service.

Industry Context

The granting of stock-based compensation is a common practice in the biotechnology industry to attract and retain key personnel and align their interests with the company's long-term success.

Comparison to Industry Standards

• Stock-based compensation, such as RSUs, is a standard practice in the biotech industry, often used to incentivize executives and directors.
• The four-year vesting schedule is also typical, aligning with long-term value creation goals.
• Many comparable biotech companies use similar incentive plans to attract and retain talent.

Stakeholder Impact

• The RSU grant may have a slightly dilutive effect on existing shareholders as new shares are issued upon vesting.
• The grant incentivizes the director to work towards the long-term success of the company, which is beneficial for all stakeholders.

Key Dates

Keywords

restricted stock units, RSUs, stock grant, director, incentive plan, Tevogen Bio Holdings, equity compensation, vesting